menu search

Docgo alert: bragar eagel & squire, p.c. reminds investors that a class action lawsuit has been filed against docgo, inc. and encourages investors to contact the firm

NEW YORK, Nov. 03, 2023 (GLobE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stock...

November 4, 2023, 1:00 am

R1 rcm alert: bragar eagel & squire, p.c. is investigating r1 rcm corp. on behalf of r1 rcm stockholders and encourages investors to contact the firm

NEW YORK, Nov. 03, 2023 (GLobE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stock...

November 4, 2023, 1:00 am

The weekly bottom line: the fed’s door is still open

U.S. Highlights The Federal Reserve’s policy statement took center stage this week. As expected, the Fed kept policy rates unchanged but preserved t...

November 4, 2023, 12:36 am

Investors sue barclays for inaccurately disclosing ex-ceo’s ties to jeffrey epstein – hagens berman

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Barclays PLC (BCS) Investors with Substantial Losses to Contact Firm’s Attorneys, Securities Fra...

November 4, 2023, 12:22 am

Canon isn't picture-perfect

Canon has operational advantages in its printing segment and has a strong global presence in various ma...

November 4, 2023, 12:12 am

Seacor marine: good company, but not good enough

The OSV market is expected to face a deficit due to low order book levels and declining shipyard capacity, but growing demand from deep-water protects...

November 4, 2023, 12:05 am

South korea's exports rebound in october 2023

South Korea's exports to mainland China have remained weak during 2023, recording a decline of 9.5% y/y in Oct...

November 4, 2023, 12:04 am

Regal rexnord corporation (rrx) q3 2023 earnings call transcript

Regal Rexnord Corporation (NYSE:RRX ) Q3 2023 Earnings Conference Call November 2, 2023 10:00 AM ET Company Participants R...

November 3, 2023, 11:54 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients W...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients W...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients W...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients W...

November 3, 2023, 11:30 pm

Correction: national youth prevention summit highlights colorado campaign to protect teens from fentanyl

This release has been corrected to identify the source as SE2 Denver, Colo., Nov. 03, 2023 (GLobE NEWSW...

November 3, 2023, 11:10 pm

Vitesse energy, inc. (vts) q3 2023 earnings call transcript

Vitesse Energy, Inc. (NYSE:VTS ) Q3 2023 Earnings Conference Call November 2, 2023 9:00 AM ET Company Participants Ben Messier - Director, IR B...

November 3, 2023, 11:03 pm


Search within

Pages Search Results: